With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.

More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.

Results from the DAPT-MVD trial, while not necessarily generalizable, do open the door to a new tactic in select cases.

Without changes, including initiatives that help everyone at risk, past progress in slowing IHD’s damage may be further ...

Without changes, including initiatives that help everyone at risk, past progress in slowing IHD’s damage may be further decimated.

The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.

Contact Laura with topics you’d like to see featured on our site, story ideas from your institution, and feedback on our current content.

The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.

The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...

Differences in various efficiency metrics were modest, but “minutes matter in stroke,” Shyam Prabhakaran says.

More than one in 10 patients with no coronary calcium had noncalcified plaque, putting them at greater risk for MACE.

Several years ago, I took care of a patient in her 50s who had just returned from overseas. During that trip, she lost her partner in a hiking accident. When she came to the hospital, she was grieving ...